In late May, thousands of developers, system administrators, engineering managers, and open-source advocates came together ...

JEP 401, integrated into JDK 28, introduces value objects. These new class instances feature final fields, altered behavior ...

Turning Point Action-backed candidate Ralph Heap defeated incumbent Nick Myers in the GOP primary for the Arizona Corporation Commission. A general election victory for Heap would give the ...

Republican challenger Ralph Heap and incumbent Kevin Thompson will represent the Republican party in November in the fight for two seats on the Arizona Corporation Commission. The Associated Press ...

PHOENIX — Election officials in Arizona's most populous county reached an agreement this week on how to jointly oversee the vote, ending a prolonged legal battle. Republican Maricopa County Recorder ...

The Maricopa County Board of Supervisors and County Recorder Justin Heap have reached a settlement, ending a year-and-a-half long legal battle over election administration. The agreement splits ...

PHOENIX — After a year and a half of legal wrangling, the battle over who controls early voting in Maricopa County is over. The Board of Supervisors voted Tuesday – just one week before Arizona’s ...

SEOUL/NEW YORK, July 10 (Reuters) - SK Hynix (000660.KS), opens new tab Chief Executive Kwak Noh-jung said the global memory industry is heading for its worst-ever supply shortage in 2027, forecasting ...

PHOENIX — The Arizona Supreme Court has sided with Maricopa County Recorder Justin Heap in his battle with the Board of Supervisors over early voting, but voters casting ballots won’t experience any ...

AMD has acquired memory optimization startup MEXT, bringing predictive memory optimization software into its AI infrastructure portfolio as enterprises look for ways to manage increasingly ...

People with Alzheimer’s disease who took the common supplement glucosamine were 25% more likely to die within five years than those who didn’t. That’s the key finding of a new study that my colleagues ...

After a decade of cognitive and functional decline, an 80-year-old patient with advanced Alzheimer’s disease showed remarkable signs of progress. All it took was a single dose of an experimental ...